What Cancers Cause Elevated Ferritin Levels?

Ferritin is a protein found inside cells that serves as the body’s primary iron storage unit, safely sequestering iron atoms and making them available when needed. A serum ferritin test measures the amount of this protein circulating in the blood, providing an indirect estimate of the body’s total iron reserves. While low levels indicate iron-deficiency anemia, high ferritin, or hyperferritinemia, is a common laboratory result signaling a need for further medical evaluation. Ferritin is considered a non-specific finding because it increases dramatically in response to various systemic disturbances, not just iron status. This elevation is often a temporary response to inflammation, though it can be associated with significant conditions, including certain types of cancer.

Understanding Ferritin’s Dual Role

Ferritin functions in a dual capacity, acting as both an iron storage mechanism and a protein involved in the immune response. As an acute phase reactant, ferritin levels rise sharply when the body experiences systemic inflammation, infection, or cellular damage. When inflammation occurs, immune cells and the liver increase their production and release of ferritin into the bloodstream. This reaction is part of the body’s defense strategy, hypothesized to reduce the amount of free-circulating iron that certain pathogens might use to grow and multiply.

Because of this inflammatory response, ferritin levels can elevate independently of the body’s actual iron stores, making interpretation complex. This means a person can have high ferritin due to systemic inflammation while simultaneously having normal or even low iron stores. This mechanism of release from activated macrophages and damaged cells is why many diseases, including malignancies, cause high ferritin without involving iron overload. The protein’s presence in the serum is largely a leakage product from damaged cells, making it a marker of cell stress.

Malignancies Most Linked to High Ferritin

Ferritin elevation in cancer patients occurs through multiple pathways, including the generalized inflammatory response to a large tumor burden or, in some cases, the direct production of ferritin by the cancer cells themselves. Hematologic malignancies are particularly known for their frequent association with hyperferritinemia. Acute leukemias, such as acute myeloid leukemia, often present with elevated ferritin, which can indicate a high tumor burden at diagnosis.

Lymphomas, especially Hodgkin’s disease, are another group of blood cancers where high ferritin is a recognized finding. The elevated levels often reflect the massive inflammatory reaction and cellular turnover caused by the rapidly growing tumor cells. Myelodysplastic syndromes (MDS) are also highly linked to elevated serum ferritin, with over 90% of patients showing high levels at diagnosis. This is frequently due to the associated ineffective blood cell production and subsequent secondary iron overload from frequent blood transfusions, which are a common treatment for MDS.

Among solid tumors, Hepatocellular Carcinoma (HCC), which is liver cancer, is one of the most frequently cited malignancies associated with high ferritin. Since the liver is the primary site of iron storage and ferritin production, damage to liver tissue from the tumor can cause a direct release of ferritin into the bloodstream. Other widespread solid tumors, including cancers of the breast, lung, colon, and kidney, can also cause ferritin elevation. This elevation in solid tumors is typically mediated by generalized systemic inflammation rather than direct iron overload. High ferritin has been correlated with poor survival in certain cancers like non-small-cell lung cancer.

Common Non-Cancer Causes of High Ferritin

Non-malignant conditions are significantly more common causes of elevated ferritin than cancer. Liver disease is perhaps the most frequent cause, as the liver’s role in iron metabolism and its susceptibility to inflammation means that any hepatic damage results in the leakage of ferritin from damaged cells.

Primary Non-Malignant Causes of High Ferritin

  • Liver disease, including non-alcoholic fatty liver disease (NAFLD), hepatitis, and heavy alcohol use.
  • Chronic inflammatory disorders, such as rheumatoid arthritis, systemic lupus erythematosus, and adult-onset Still’s disease, which drive sustained overproduction of ferritin.
  • Acute and chronic infections, whether viral or bacterial, which trigger the inflammatory release of ferritin.
  • Hereditary hemochromatosis, an inherited disorder causing true iron overload where excess iron is stored in organs, substantially raising ferritin levels, often exceeding 1,000 micrograms per liter (µg/L).
  • Metabolic syndrome, encompassing obesity, type 2 diabetes, and hypertension, which causes chronic, low-grade inflammation contributing to hyperferritinemia.

A comprehensive clinical picture is necessary to distinguish between these common benign causes and a potential malignancy.

Clinical Investigation of Elevated Ferritin

When elevated ferritin is detected, a physician initiates a systematic investigation to differentiate between the common causes of inflammation, iron overload, and malignancy. The initial step involves a detailed patient history, focusing on alcohol intake, family history of iron disorders, and any symptoms suggestive of infection or chronic disease. Laboratory workup includes additional tests to assess the nature of the elevation and overall iron status.

The C-Reactive Protein (CRP) test is frequently ordered alongside ferritin; a high CRP confirms an active inflammatory process. Iron status is further clarified by checking the Transferrin Saturation (TSAT) and Total Iron Binding Capacity (TIBC). A pattern of very high ferritin with a low TSAT strongly suggests inflammatory elevation, as the body is sequestering iron. High ferritin accompanied by a high TSAT (above 45%) is highly suggestive of iron overload, such as hemochromatosis.

Liver function tests (LFTs), including ALT and GGT, are also performed, as abnormal results may point toward liver disease as the source of the hyperferritinemia. If the initial bloodwork points toward iron overload, genetic testing for the HFE gene mutation, which causes hereditary hemochromatosis, may be pursued.

If inflammation is the likely cause but no obvious infection or rheumatologic condition is found, and especially if the ferritin level is significantly elevated (e.g., above 1,000 µg/L), the physician may then consider malignancy and other rare inflammatory syndromes, guiding further specialized imaging or testing. Ultimately, an elevated ferritin level is a valuable laboratory signal, but it must be correlated with a complete clinical assessment.